BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 19261387)

  • 1. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis.
    Tsoumpou I; Arbyn M; Kyrgiou M; Wentzensen N; Koliopoulos G; Martin-Hirsch P; Malamou-Mitsi V; Paraskevaidis E
    Cancer Treat Rev; 2009 May; 35(3):210-20. PubMed ID: 19261387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 4. P16 immunostaining and HPV testing in histological specimens from the uterine cervix.
    Capobianco G; Marras V; Wenger JM; Santeufemia DA; Ambrosini G; Lutzoni R; Dessole M; Cherchi PL
    Eur J Gynaecol Oncol; 2013; 34(3):227-30. PubMed ID: 23967551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
    Zhang G; Yang B; Abdul-Karim FW
    Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-risk human papillomavirus DNA test and p16(INK4a) in the triage of LSIL: a prospective diagnostic study.
    Tsoumpou I; Valasoulis G; Founta C; Kyrgiou M; Nasioutziki M; Daponte A; Koliopoulos G; Malamou-Mitsi V; Karakitsos P; Paraskevaidis E
    Gynecol Oncol; 2011 Apr; 121(1):49-53. PubMed ID: 21194734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies.
    Nieh S; Chen SF; Chu TY; Lai HC; Lin YS; Fu E; Gau CH
    Gynecol Oncol; 2005 Apr; 97(1):35-40. PubMed ID: 15790434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
    Murphy N; Ring M; Killalea AG; Uhlmann V; O'Donovan M; Mulcahy F; Turner M; McGuinness E; Griffin M; Martin C; Sheils O; O'Leary JJ
    J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16/Ki-67 dual staining in cervico-vaginal cytology: correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy.
    Donà MG; Vocaturo A; Giuliani M; Ronchetti L; Rollo F; Pescarmona E; Carosi M; Vocaturo G; Benevolo M
    Gynecol Oncol; 2012 Aug; 126(2):198-202. PubMed ID: 22588180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.
    Carozzi F; Confortini M; Dalla Palma P; Del Mistro A; Gillio-Tos A; De Marco L; Giorgi-Rossi P; Pontenani G; Rosso S; Sani C; Sintoni C; Segnan N; Zorzi M; Cuzick J; Rizzolo R; Ronco G;
    Lancet Oncol; 2008 Oct; 9(10):937-45. PubMed ID: 18783988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of P16(INK4a) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology.
    Carozzi F; Cecchini S; Confortini M; Becattini V; Cariaggi MP; Pontenani G; Sani C; Ciatto S
    Cancer; 2006 Apr; 108(2):119-23. PubMed ID: 16411180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sorting role of p16(INK4a)/Ki-67 double immunostaining in the cervical cytology specimens of ASCUS and LSIL cases].
    Yu J; Zhu HT; Zhao JJ; Su JZ; Xia YD
    Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):323-326. PubMed ID: 28468038
    [No Abstract]   [Full Text] [Related]  

  • 13. An evaluation of the diagnostic and prognostic significance of p16(INK4a) /p21(WAF1/Cip1) immunostaining in squamous intraepithelial lesions of the uterine cervix using liquid-based cytology specimens.
    Ishida K; Araki A; Kobayashi M; Taniyama K; Nabika T; Nagasaki M
    Diagn Cytopathol; 2014 Feb; 42(2):125-33. PubMed ID: 23754829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.
    Wright TC; Behrens CM; Ranger-Moore J; Rehm S; Sharma A; Stoler MH; Ridder R
    Gynecol Oncol; 2017 Jan; 144(1):51-56. PubMed ID: 28094038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
    Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
    Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.
    Wentzensen N; Schwartz L; Zuna RE; Smith K; Mathews C; Gold MA; Allen RA; Zhang R; Dunn ST; Walker JL; Schiffman M
    Clin Cancer Res; 2012 Aug; 18(15):4154-62. PubMed ID: 22675168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using biomarkers as objective standards in the diagnosis of cervical biopsies.
    Galgano MT; Castle PE; Atkins KA; Brix WK; Nassau SR; Stoler MH
    Am J Surg Pathol; 2010 Aug; 34(8):1077-87. PubMed ID: 20661011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical assessment of p16 and HPV L1 capsid protein in cervical squamous intraepithelial lesions.
    Balan R; Giuşcă S; Căruntu ID; Gheorghiţă V; Neacşu D; Amălinei C
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1118-24. PubMed ID: 21495457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are adjunctive markers useful in routine cervical cancer screening? Application of p16(INK4a) and HPV-PCR on ThinPrep samples with histological follow-up.
    Schledermann D; Andersen BT; Bisgaard K; Dohse M; Ejersbo D; Hoelund B; Horal P; Lindh M; Ryd W
    Diagn Cytopathol; 2008 Jul; 36(7):453-9. PubMed ID: 18528890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature.
    Yildiz IZ; Usubütün A; Firat P; Ayhan A; Küçükali T
    Pathol Res Pract; 2007; 203(6):445-9. PubMed ID: 17543474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.